Incyte Corp. operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Incyte Corp. with three other
companies in this sector in the United States:
Insys Therapeutics Incorporated
sales of $330.80 million
of which 100%
was Non-Drug Products),
Albany Molecular Research Incorporated
of which 54%
was API), and
Five Prime Therapeutics Inc
During the year ended December of 2015, sales at
Incyte Corp. were $753.75 million.
increase of 47.4%
versus 2014, when the company's sales were $511.50 million.
This was the fourth straight year of sales growth at Incyte Corp..